SciSparc Ltd. has signed a binding term sheet to acquire a portfolio of patents, trademarks, and intellectual property rights related to innovative endoscopic systems and medical cameras, including the MUSE™ system, from Xylo Technologies Ltd. The MUSE™ system is a single-use, minimally invasive endoscopic device for treating gastroesophageal reflux disease (GERD) via transoral fundoplication. As consideration for the acquired assets, SciSparc will issue new ordinary shares representing 19.99% of its issued and outstanding share capital to Xylo, with the option to issue pre-funded warrants instead. Building on previous commercialization efforts in Greater China, SciSparc plans to expand the MUSE™ system's reach into additional global markets through exclusive regional partnerships.